BRIEF: Hengrui executive to sell nearly 500,000 A-shares
Pharmaceutical company Jiangsu Hengrui Pharmaceuticals Co. Ltd. (1276.HK; 600276.SH) said on Sunday that executive director and senior vice president Sun Jieping will sell up to 476,700 of his A-shares in…
BRIEF: Bayzed Health to raise up to $115 million in Hong Kong IPO
Cancer hospital operator Bayzed Health Group Inc. (2609.HK) launched its Hong Kong IPO on Friday, aiming to raise up to HK$900 million ($115 million). The company said it plans to…
BRIEF: XtalPi acquires British chiral molecule developer
AI drug discovery company XtalPi Holdings Ltd. (2228.HK) said on Thursday it has acquired Liverpool ChiroChem Technologies Ltd. (LCC), a developer of novel molecules specializing in chiral molecules. It did not disclose…
BRIEF: Gavi seeks to claw back $224 million prepayment from Clover
Biotechnology firm Clover Biopharmaceuticals Ltd. (2197.HK) said on Monday that it received an arbitration claim on June 6 seeking return of a $224 million prepayment from global vaccine alliance Gavi.…
BRIEF: Kelun-Biotech raises $250 million through share placement
Innovative cancer drug company Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. (6990.HK) announced on Thursday it plans to sell 5.92 million shares through a placement, representing 2.54% of its enlarged share capital.…
BRIEF: Dobot partners with YSB on pharmacy-focused robots
Robot manufacturer Shenzhen Dobot Corp. Ltd. (2432.HK) on Tuesday announced a strategic collaboration with YSB Inc. (9885.HK) to jointly develop robots for pharmaceutical applications. The partnership will see Dobot spearhead…
BRIEF: PegBio slumps in Hong Kong trading debut
Shares of biopharmaceutical company PegBio Co. Ltd. (2565.HK) slumped in their Hong Kong trading debut on Tuesday. The stock opened at HK$13, down 6.67% from its IPO price of HK$15.60,…